Louis Lehot and Eric Chow Author Overview of Potential Issues in M&A Due Diligence
27 March 2024
Foley & Lardner LLP partners Louis Lehot and Eric Chow authored the Westlaw article, “Due diligence vs. protections and remedies for buyers in acquisitions,” providing an overview of hidden issues sometimes discovered during the due diligence stage of the acquisition process.
The authors explore the structure of a transaction, insurance, indemnification, negotiation of remedies, escrow, and holdback, and the importance of continued due diligence even after a transaction is completed.
“It is essential to consider and address these kinds of protections upfront and know your options should you find yourself facing a surprise when the deal is done,” they conclude.
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”